Initiation of the tissue factor pathway of coagulation in the presence of heparin: Control by antithrombin III and tissue factor pathway inhibitor

Blood

Volumn 87, Issue 6, 1996, Pages 2301-2307

  Jesty, Jolyon ^a   Lorenz, Ann ^b   Rodriguez, José ^b   Wun, Tze Chein ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 10; HEPARIN; THROMBOPLASTIN;

ARTICLE; BLOOD CLOTTING; DRUG MECHANISM; ENZYME ACTIVATION; FIBRINOLYTIC THERAPY; HUMAN; PRIORITY JOURNAL;

EID: 0029939395     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.6.2301.bloodjournal8762301     Document Type: Article

References (35)

1. Broze GJ Jr, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP: The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: Insight into its possible mechanism of action. Blood 71:335, 1988
2. Warn-Cramer BJ, Rao LV, Maki SL, Rapaport SI: Modifications of extrinsic pathway inhibitor (EPI) and factor Xa that affect their ability to interact and to inhibit factor VIIa/tissue factor: Evidence for a two-step model of inhibition. Thromb Haemost 60:453, 1988
3. Girard TJ, Warren LA, Novotny WF, Likert KM, Brown SG, Miletich JP, Broze GJ, Jr: Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature 338:518, 1989
4. Broze GJ Jr, Girard TJ, Novotny WF: Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry 29:7539, 1990
5. Callander NS, Rao LV, Nordfang O, Sandset PM, Warn-Cramer B, Rapaport SI: Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor Xa. J Biol Chem 267:876, 1992
6. Warr TA, Warn-Cramer BJ, Rao LV, Rapaport SI: Human plasma extrinsic pathway inhibitor activity. I. Standardization of assay and evaluation of physiologic variables. Blood 74:201, 1989
7. Warr TA, Rao LV, Rapaport SI: Human plasma extrinsic pathway inhibitor activity. II. Plasma levels in disseminated intravascular coagulation and hepatocellular disease. Blood 74:994, 1989
8. Novotny WF, Brown SG, Miletich JP, Rader DJ, Broze GJ Jr: Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples. Blood 78:387, 1991
9. Novotny WF, Girard TJ, Miletich JP, Broze GJ Jr: Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor. Blood 72.2020, 1988
10. Sandset PM, Abildgaard U, Larsen ML: Heparin induces release of extrinsic coagulation pathway inhibitor (EPI). Thromb Res 50:803, 1988
11. Abildgaard U, Lindahl AK, Sandset PM: Heparin requires both antithrombin and extrinsic pathway inhibitor for its anticoagulant effect in human blood. Haemostasis 21:254, 1991
12. Novotny WF, Palmier M, Wun TC, Broze GJ Jr, Miletich JP: Purification and properties of heparin-releasable lipoprotein-associated coagulation inhibitor. Blood 78:394, 1991
13. Lindahl AK, Abildgaard U, Larsen ML, Staalesen R, Hammer AK, Sandset PM, Nordfang O, Beck TC: Extrinsic pathway inhibitor (EPI) released to the blood by heparin is a more powerful coagulation inhibitor than is recombinant EPI. Thromb Res 62:607, 1991
14. Nordfang O, Bjrn SE, Valentin S, Nielsen LS, Wildgoose P, Beck TC, Hedner U: The C-terminus of tissue factor pathway inhibitor is essential to its anticoagulant activity. Biochemistry 30.10371, 1991
15. Wun TC, Kretzmer KK, Palmier MO, Day KC, Huang MD, Welsch DJ, Lewis C, Wolfe RA, Zobel JF, Lange GW, Frazier RB, Bild GS, Peel MA, Shell RE, Horn NA, Junger JD, Foy BA, Gustafson ME, Leimgruber RM, Novotny WF, Broze GJ Jr, Pyla YE, Hippenmeyer PJ, Warren TG: Comparison of recombinant tissue factor pathway inhibitors expressed in human SK hepatoma, mouse C127, baby hamster kidney, and Chinese hamster ovary cells. Thromb Haemost 68:54, 1992
16. Wesselschmidt R, Likert K, Huang Z, MacPhail L, Broze GJ Jr: Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparin. Blood Coag Fibrinol 4:661, 1993
17. Wun TC: Lipoprotein-associated coagulation inhibitor (LACI) is a cofactor for heparin: Synergistic anticoagulant action between LACI and sulfated polysaccharides. Blood 79:430, 1992
18. Nordfang O, Kristensen HI, Valentin S, Ostergaard P, Wadt J: The significance of TFPI in clotting assays - Comparison and combination with other anticoagulants. Thromb Haemost 70:448, 1993
19. Huang ZF, Wun TC, Broze GJ Jr: Kinetics of factor Xa inhibition by tissue factor pathway inhibitor. J Biol Chem 268:26950, 1993
20. Jesty J, Wun TC, Lorenz A: Kinetics of the inhibition of factor Xa and the tissue factor-factor VIIa complex by the tissue factor pathway inhibitor in the presence and absence of heparin. Biochemistry 33:12686, 1994
21. Jesty J: Analysis of the generation and inhibition of activated coagulation factor X in pure systems and human plasma. J Biol Chem 261:8695, 1986
22. Morrison SA, Jesty J: Tissue factor - dependent activation of tritium-labeled factor IX and factor X in human plasma. Blood 63:1338, 1984
23. Yamamoto M, Nakagaki T, Kisiel W: Tissue factor - dependent autoactivation of human blood coagulation factor VII. J Biol Chem 267:19089, 1992
24. Neuenschwander PF, Morrissey JH: Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of factor VII but not cofactor function. Analysis of a mutant with a selective deficiency in activity. J Biol Chem 267:14477, 1992
25. Morrissey JH, Macik BG, Neuenschwander PF, Comp PC: Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 81:734, 1993
26. Lawson JH, Butenas S, Ribarik N, Mann KG: Complex dependent inhibition of factor VIIa by antithrombin III and heparin. J Biol Chem 268:767, 1993
27. Rao LV, Rapaport SI, Hoang AD: Binding of factor VIIa to tissue factor permits rapid antithrombin III/heparin inhibition of factor VIIa. Blood 81:2600, 1993
28. Broze GJ Jr, Likert K, Higuchi D: Inhibition of factor VIIa/ tissue factor by antithrombin III and tissue factor pathway inhibitor. Blood 82:1679, 1993 (letter)
29. Jesty J, Nemerson Y: The activation of bovine coagulation factor X. Methods Enzymol 45:95, 1976
30. Jesty J: The inhibition of activated bovine coagulation factors X and VII by antithrombin III. Arch Biochem Biophys 185:165, 1978
31. Diaz-Collier JA, Palmier MO, Kretzmer KK, Bishop BF, Combs RG, Obukowicz MG, Frazier RB, Bild GS, Joy WD, Hill SR, Duffin KL, Gustafson ME, Junger KD, Grabner RW, Galluppi GR, Wun TC: Refold and characterization of recombinant tissue factor pathway inhibitor expressed in Escherichia coli. Thromb Haemost 71:339, 1994
32. Waxman E, Ross JB, Laue TM, Guha A, Thiruvikraman SV, Lin TC, Konigsberg WH, Nemerson Y: Tissue factor and its extracellular domain: The relationship between intermolecular association with factor VIIla and enzymatic activity of the complex. Biochemistry 31:3998, 1992
33. Jesty J. Dissociation of complexes and their derivatives formed during inhibition of bovine thrombin and activated factor X by antithrombin III. J Biol Chem 254:1044, 1979
34. Silverberg SA, Nemerson Y, Zur M: Kinetics of the activation of bovine coagulation factor X by components of the extrinsic pathway. J Biol Chem 252:8481, 1977
35. Rao LVM, Nordfang O, Hoang AD, Pendurthi UR: Mechanism of antithrombin III inhibition of factor VIIa/tissue factor activity on cell surfaces. Comparison with tissue factor pathway inhibitor/ factor Xa - induced inhibition of factor VIIa/tissue factor activity. Blood 85:121, 1995